EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY 4.0

Clinical effectiveness of finasteride versus hydroxychloroquine in the treatment of frontal fibrosing alopecia: A randomized controlled trial

Mina Saber iD, Maryam Farokhshahi, Farahnaz Fatemi Naeini iD, Fatemeh Mohaghegh iD, Ali Asilian

Journal of Cosmetic Dermatology · 2024

DOI: 10.1111/jocd.15993 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Journal of Cosmetic Dermatology, 2024. Verfasst von Mina Saber und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Skin Diseases and Leishmaniasis Research Center, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran. Hauptthemen laut MEDLINE: Finasteride, Lichen Planus. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Frontal fibrosing alopecia (FFA) is a cicatricial alopecia with rapid epidemic growth. However, there is no agreement on the best therapeutic approach.

Aims

To compare the therapeutic effects of finasteride as a first‐line systemic treatment of FFA versus hydroxychloroquine as a relatively safe and effective immunosuppressive drug.

Methods

Thirty‐four female FFA patients were randomly assigned to receive either 400 mg/day of hydroxychloroquine or 2.5 mg/day of finasteride for 6 months. Topical treatments in both groups include pimecrolimus, mometasone, and minoxidil. Treatment efficacy was evaluated using the Frontal Fibrosing Alopecia Severity Score (FFASS), photography, and trichoscopy after 3 and 6 months.

Results

Both the finasteride and hydroxychloroquine groups showed significant improvements in FFASS and trichoscopic scores ( p < 0.01). However, there was no significant difference between the two groups during the study. Photographic assessment showed that more than 60% of patients in both groups had improved without statistically significant differences between the two groups.

Conclusions

Both finasteride and hydroxychloroquine are equally effective, safe, and well‐tolerable for treating FFA patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FinasterideLichen PlanusHumansFemaleHydroxychloroquineAlopeciaTreatment OutcomeMinoxidil

Stichwörter der Autor:innen

FFASSfinasteridefrontal fibrosing alopeciahydroxychloroquinescarring alopecia

Substanzen

FinasterideHydroxychloroquineMinoxidil

Autor:innen und Institutionen

  • Department of Dermatology, Skin Diseases and Leishmaniasis Research Center, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.

ORCID-Profile: Mina Saber, Farahnaz Fatemi Naeini, Fatemeh Mohaghegh

Zitieren

APA

Saber, M., Farokhshahi, M., Fatemi Naeini, F., Mohaghegh, F., & Asilian, A. (2024). Clinical effectiveness of finasteride versus hydroxychloroquine in the treatment of frontal fibrosing alopecia: A randomized controlled trial. Journal of Cosmetic Dermatology. https://doi.org/10.1111/jocd.15993

Vancouver

Saber M, Farokhshahi M, Fatemi Naeini F, Mohaghegh F, Asilian A. Clinical effectiveness of finasteride versus hydroxychloroquine in the treatment of frontal fibrosing alopecia: A randomized controlled trial. Journal of Cosmetic Dermatology. 2024. doi:10.1111/jocd.15993

BibTeX
@article{Saber2024,
  author = {Saber, Mina and Farokhshahi, Maryam and Fatemi Naeini, Farahnaz and Mohaghegh, Fatemeh and Asilian, Ali},
  title = {Clinical effectiveness of finasteride versus hydroxychloroquine in the treatment of frontal fibrosing alopecia: A randomized controlled trial},
  journal = {Journal of Cosmetic Dermatology},
  year = {2024},
  doi = {10.1111/jocd.15993}
}
Kostenlos starten →